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Interest of the SYNTAX Score to predict cardiovascular outcomes
after stenting of unprotected left main coronary artery stenosis :
2 Years Follow-up of the ALMA registry
Jean-Guillaume Dillinger, Akram Drissa, Georgios Sideris, Victor Stra-
tiev, Damien Logeart, Patrick Henry
CHU Lariboisière, Departement de Cardiologie, Paris, France
Aims: The SYNTAX (SX) score, an interesting tool to characterize the
severity of the coronary artery disease was designed to predict cardiovascular
outcomes in patients with three-vessel or unprotected left main coronary artery
(ULMCA) disease in the SYNTAX study. However, the prognostic value of
SX score in patients undergoing percutaneous coronary intervention (PCI) of
ULMCA stenosis needs to be validated in the “real world”. The aim of our
study was to evaluate the clinical outcome of all the patients undergoing PCI
for ULMCA stenosis according to the SX score in a monocentric registry. 
Methods and results: Forty-five patients with de novo ULMCA stenosis
(mean age 72±10 years; 76% of male) underwent PCI with bare metal stent
(BMS) or drug eluting stent (DES) from January 2006 to December 2008 and
were included in the ALMA (Angioplasty of Left Main at lAriboisière hos-
pital) registry. Twenty nine percent of patients were diabetics, mean ejection
fraction (EF) was 54±10%. EuroSCORE value was 5.4±3.2 and SX score was
22±8. Ostial ULMCA stenosis was involved in 27% and distal ULMCA lesion
in 62% of cases. Distal ULMCA stenoses were treated by provisional T
stenting in most of the cases, with one stent implantation in 48% of patients
and with two stents in 44%. Clinical follow-up was achieved in all patients
(25±10 months). In-hospital MACCE occurred in 6.7% of patients (2 death
and 1 myocardial infarction). The rate of major adverse cardiac or cerebrovas-
cular events (MACCE) was 35.6%. Cardiac mortality in the registry was 8.8%
at two years. Target lesion revascularisation occurred in 15.6% of patients
(7.1% in the DES group vs. 19.4% in the BMS group; p=0.31). None of the
patients showing restenosis died. SX score was correlated to MACCE and car-
diovascular death. A higher SX score (≥33) compared to the lower group (SX
score between 0 to 32) is significantly associated with MACCE (83,3% vs.
28,1%; p<0.01) and cardiac mortality (33.3% vs. 7.7%; p=0.04).
Conclusions: The SX score is a useful tool to predict MACCE and cardiac
mortality in patients undergoing percutaneous revascularization of the left
main coronary artery.
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Coronary stent thrombosis of drug eluting stent in daily clinical prac-
tice: analysis of a tertiary single center registry
Leila Abid (1), Rania Hammami (1), Slim Chtourou (1), Mohamed Ben
Rjab (2), Salma Krichène (1), Mohamed Sahnoun (1), L Laroussi (1), S
Mallek (1), Dorra Abid (1), Faten Triki (1), Mourad Hentati (1), Samir
Kammoun (1)
(1) CHU Hédi Chaker, Cardiologie, Sfax, Tunisie – (2) Médecine commu-
nautaire, Sousse, Tunisie
The large reduction in restenosis rates with drug-eluting stents (DES), com-
pared with bare-metal stents (BMS), has already been demonstrated. In those
studies this gain was not associated with safety concerns such as excess early
and late stent thrombosis (ST). 
We tried to determine predictive factors of drug eluting instent thrombosis in
a tertiary center.
Our study is retrospective enrolling 619 patients who underwent drug
eluting stenting. Thrombosis definition was based on the Academic Research
Consortium (ACR 2008), We compared 2 groups T+ (thrombosis) et T- (no
thrombosis).
The rate of thrombosis was 3,7% (23 patients among 619). This complica-
tion occurred at a mean follow-up of 21,43 days. There were one case of acute
thrombosis, 21 cases of subacute Thrombosis, one case of late thrombosis. No
very late thrombosis was noted. Patients who had thrombosis were older (T+=
67years old; T-=63,16 years old), more diabetic (T+=65% ; T-=61,5%) but
without significant difference . The occurring of stent thrombosis didn’t
depend on the site nor on the technic of implantation. There was no correlation
between this complication and stent sizes despite that it seems to be more fre-
quent in the case of longer stents (T+=24,32 ;T- = 22,13 ; p=0,47) and in the
case of small diameter (T+= 2,82 ;T-=2,94 ; p=0,36). Predictive factors of
stent thrombosis were clopidogrel withdrawal for surgery (T+=43,47% ; T-
=27,51 %; p=0,09), the early withdrawal of clopidogrel (T+=13,99 mois ; T-=
9,08mois ;p=0,02). Stent thrombosis was associated to the increase of major
cardiovascular events (T+=39,13% ;T =9,7% ;p<0,001) especially myocardial
infarction (T+= 21,7% ;T-= 1,67 ; p<0,001), the rate of revascularisa-
tion(T+=13,04 ; T-=3,35% ;p=0,01) but there was no significant effect on the
mortality (T+= 8,6% ;T-= 3,02% ;p=0,13).
Instent thrombosis is a lifethreatening complication occurring in 0 to 3,5%
based on randomized studies. It is more frequent in case of drug eluting stenting.
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Unprotected left main coronary artery angioplasty in octogenarians:
characteristics, results and predictors of long term outcomes
Sofiene Rekik, Jerome Brunet, Francois Xavier Hager, Gilles Bayet, Lau-
rent Meille, Jean Michel Quatre, Joel Sainsous
Clinique Rhone Durance, Cardiologie, Avignon, France
Aim: To describe the characteristics and results of Percutaneous coronary
intervention (PCI) for unprotected left main coronary artery (ULMCA) disease
in octogenarians and to outline the predictors of outcomes
Methods: 80 consecutive patients≥80 years that underwent ULMCA
angioplasty in our institution between 2004 and 2008 were included. The Cox
regression model was used to analyse long term predictors of Major adverse
cardiac events (cardiac death, non fatal Q wave MI, or TLR). 
Results: Mean age was 84 ±3.4 years. 49 (61.3%) were men, 19 (23.8%) had
diabetes mellitus.11 (13.8%) patients presented with STEMI, 43 (54%) with
NSTEMI/UA, 9 (11.3%) with stable angina, 14 (17.5%) with silent ischemia and
1 (1.3%) with syncope. Mean additive EuroSCORE value was 10.8±3.8 and
mean predicted surgical mortality by logistic EuroSCORE was 26.7%. 28
patients (54.9%) had 3-vessel disease. Distal Left main lesions were found in 46
cases (57.5%). the provisional side-branch T-stenting approach with kissing bal-
loon inflation was used in 92.3% of cases. Drug eluting stents were used in only
14 patients (27%). Angiographic success was obtained in all cases. 
After a mean follow up of 30.42 months, 8 (10%) cardiac deaths were
recorded, 8 (10%) patients had TLR, combined MACE occurred in 17 patients
(21.3%).
By univariate analysis, only left ventricular ejection fraction<50%
(p=0.025; HR=5.08, 95% CI [1.1-15.4]) and EuroSCORE values>10 (p=0.004;
HR=8.09, 95% CI [3.3-35.4]) were associated with a higher incidence of long
term cardiac death, but on multivariate analysis, EuroSCORE was the only
independent predictor of cardiac death (p=0.01; HR=8.4, 95% CI [4.1-28.4]).
Similarly, higher EuroSCORE values constituted the only variable associated
with MACE (p=0.034; HR=3.2, 95% CI [1.1-9.4]).
Conclusion: ULMCA stenting in octogenarians proved to be a feasible and
safe procedure associated with acceptable short and long term outcomes. Euro-
SCORE was the only predictor of both cardiac death and MACE. 
022
Paclitaxel Eluting Stent use in everyday practice and impact of diabe-
tes mellitus on safety and efficacy at 3 years.
Gilles Barone-Rochette (1), Gérald Vanzetto (1), Alison Foote (2), Jean-
Louis Quesada (2), Gilles Grollier (3), Jacques Machecourt (4)
(1) CHU Grenoble, USIC, Grenoble, France – (2) CHU de Grenoble, Centre
d'investigation clinique, Grenoble, France – (3) CHU de Caen, Cardiologie,
Caen, France – (4) CHU Grenoble, Cardiologie, Grenoble, France
Objectives: We sought to assess the efficacy and safety of the PES used in
everyday practice in diabetic patients (DP) with single or multiple vessel disease
compared to non-diabetic patients (NDP) over at least 3 years. Safety concerns
about PES have been raised, particularly when used in less highly selected
patients than those included in randomized trials and especially among DP. 
Methods: The EVASTENT-Tax study is a multicenter matched cohort reg-
istry of 502 patients (pts) revascularised exclusively with paclitaxel stents
(Taxus®). For each DP included a NDP patient was subsequently included.
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Patients were followed for at least 3 years (follow-up at 1 yr 98%, at ≥3 yrs
92%). The safety primary end point was a composite of cardiac death and non-
fatal myocardial infarction (with or without stent thrombosis, according to
Academic Research Consortium definitions), and for efficacy target lesion
revascularisation (TLR). Target vessel revascularisation excluding TLR (TVR)
and non TVR were also assessed. 
Results: We included 502 patients (mean age 70 years) presenting with
ACS (52%) or a stable condition (48%), but not acute MI, of who 233 were
diabetic and 381 (76%) were male. During follow-up 30 pts (6%) died, with
cardiac death in 12 pts (2.4%). Nonfatal myocardial infarction occurred in 12
pts (2%). Stent thrombosis was noted in 15 pts (3%): 4 definite (3 acute), 6
probable (1 sub-acute), and 5 possible; 4 acute or sub acute, 4 late and 7 very
late ST. At 3-years, the safety endpoint rate was significantly higher in dia-
betic than in non-diabetic patients (8% vs.1%, p ≤ 0.001), whereas TLR was
not significantly different. 
Conclusions: In everyday practice the PES has a good efficacy with com-
parable clinical parameters for restenosis in DP and NDP at 3 years. PES are
clinically safe, however the risk of paclitaxel stent thrombosis, including very
late ST, is higher for DP. 
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Percutaneous coronary intervention using drug-eluting stents in
elderly (>70 years) diabetic patients : comparison to younger patients 
Vassilis Voudris, Panagiotis Karyofillis, Sofia Thomopoulou, Dennis Cok-
kinos
Onassis Cardiac Surgery Center, Cardiology Dpt, Athens, Grèce
Purpose: The elderly (EL) constitute a rapidly expanding part of our pop-
ulation and cardiovascular disease becomes more prevalent with increasing
age. Encouraging results with the use of drug-eluting stents (DES) has been
presented in patients (pts) with coronary artery disease. In this prospective
study, we assessed the short- and long- term results of DES in diabetic (D) EL,
as compared to younger (YO) pts. 
Methods: A total of 610 consecutive pts (mean age 65±9 years) that had
been treated with DES were classified in 2 groups according to age: 1) YO pts
(N=429, age ≤70 years); 2) EL pts (N=181, age >70 years). Clinical outcome
at follow-up (FU) (median 29 months) was obtained in 98% of pts. Adverse
events at FU were considered death, myocardial infarction (MI), cerebrovas-
cular accident (CVA), bypass surgery (CABG), target (TLR) and non-target
(non-TLR) lesion revascularization. 
Results: EL group had more women (30% vs. 16%, p=0.001), a higher
incidence of hypertensive (85% vs. 77%, p=0.03), with previous CABG (25%
vs. 14%, p=0.001), and ejection fraction < 40% (15% vs. 9%, p=0.05) com-
pared to YO pts. The clinical success rate (angiographic success without death,
Q- wave MI, emergency CABG) was high (>99%) in both groups; more
bleeding complications (1.1% vs. 0%, p=0.09) were observed in EL pts. At FU
a higher rate of death (10.3% vs. 2.8%, p<0.001), CVA (4.6% vs. 0.7%,
p=0.003), and combined death/MI/CVA (15% vs. 6%, p<0.001) was observed
in EL pts; YO pts had a higher rate of non-TLR (19% vs. 11%, p=0.02). Def-
inite and probable stent thrombosis was similar in both groups, but possible
stent thrombosis was higher in EL pts (p=0.02). 
Conclusion: The long-term effectiveness of DES in EL D is lower due to
an increase risk for death or CVA, compared to YO pts.
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Validation with thallium 201 of a new cadmium-zinc-telluride (CZT)
cardiac camera
Bernard Songy, David Lussato, Mohamed Guernou, Mathieu Queneau
Centre Cardiologique du Nord, département d'imagerie scintigraphique,
Saint Denis, France
Background: novel dedicated ultrafast cardiac cameras had recently be
introduced to improve myocardial perfusion imaging
Objectives: We report the first validation study with thallium-201 and the
new GE Discovery NM 530c CZT cardiac camera.
Methods: We prospectively studied with thallium-201 153 consecu-
tive patients referred for myocardial perfusion imaging at exercise ( 111 to 148
MBq) then redistribution ( with a 37MBq reinjection). 
We performed sequential acquisitions, first with conventional dual head tomo-
graphic Anger camera (CC) in 11 to 16 mn, then with CZT camera (CZT) in
5mn, in prone then in supine position.
Results: 
– we excluded 7 patients: 1 for mispositionning, 1 for camera failure, 1 for
too late acquisition after exercise, 1 for non acceptation of redistribution by the
patient, 1 for motion of the patient.
– acquisition was more comfortable with CZT for all patients.
– counts rate was 3 times more with CZT than with CC ( 3.5 to 5 KCts/s
vs 1 to 1.5 ).
– myocardial counts rate was 6 to 8 times more with CZT than with CC.
– comparison between CZT and CC: quality of CZT images was consid-
ered as better in 38%, equal in 59% and worse in 3% of cases; diagnostic con-
clusions were the same in 137 of 146 cases (94%); discordances were 2
artifacts with CC, 1 artifact with CZT, 4 early redistributions and 2 discor-
dances about reversibility of thallium defect.
– comparison between prone and supine with CZT: quality of prone images
was considered as better in 41%, equal in 34% and worse in 25%; there were
2 times more artifacts in supine (14%) than in prone (7%) (p=0.05).
Conclusions: With thallium-201, the GE Discovery NM 530c CZT cardiac
camera allows 5 minutes acquisitions with an increased image quality and a
reliable diagnosis quality, both in prone and in supine positions.
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Validation of a “low dose thallium 201 protocol” with a cadmium-
zinc-telluride (CZT) cardiac camera
Bernard Songy, David Lussato, Mohamed Guernou, Mathieu Queneau
Centre Cardiologique du Nord, département d'imagerie scintigraphique,
Saint Denis, France
Background: Thallium 201 is the most efficient radiotracer for myocardial
perfusion imaging but leads to relative high radiation exposure for patients. 
Objectives: We used a new cardiac CZT camera to decrease the effective
dose with thallium-201 in myocardial perfusion imaging.
Methods: We prospectively studied 137 consecutive patients referred for
stress myocardial perfusion imaging and who previously had in the last 5 years
a myocardial SPECT with thallium-201. We injected at stress a low dose of
thallium 201 (1 to 1.2 MBq/kg, i.e. 74 MBq for 70kgs), performed stress myo-
cardial imaging in 5 to 7 mn with a CZT camera GE Discovery NM 530c and
redistribution imaging when initial images were abnormal, with reinjection
(37MBq) when previous myocardial infarction or severe defect or without
reinjection in other cases. We compared the CZT scan with the scan previ-
ously performed in the last 5 years with conventional dual head tomographic
Anger camera (CC) with a regular dose of thallium-201.
Results: Patients had known coronary artery diseases in 85% of cases,
myocardial scar in 38% and ischemia in 20%.
The average stress dose was 88 MBq versus 125 MBq previously (–30%)
The average time for camera acquisition was 6 mn versus 13 mn (–54%)
The cardiac counts statistic was higher with CZT (>1Mcts)
By comparison with CC, the quality of CZT images was better ( better delin-
eation of left ventricular cavity, visualization of papillary muscles, easier
thickening analysis ) in 70% of cases, equal in 24% and worse in 6% ( 6 arte-
facts, 2 digestive contaminations )
Comparison of artefacts showed 30 unmodified, 29 less and 6 additionnal arte-
facts.
By comparison with the previous SPECT, we missed no pathological image;
furthermore, we detected 5 true pathological images which were missed with
the CC.
Calculated effective dose was less than 12 mSv when no reinjection and less
than 18 mSv when reinjection
Conclusions: With reduced activities of thallium 201 ( -30% ) and effec-
tive doses between 12 and 18 mSv, CZT camera gives reliable high quality
imaging
